CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Philippines

Publisher Name:
Published Date: 5-May-2014
No. of pages: 196

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Philippines”. The report is an essential source of information and analysis regarding the healthcare, regulatory and reimbursement landscape in the Philippines. It identifies key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure in the country. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. This resource has been produced using data and information from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The population of the Philippines amounted to approximately 99.2 million in 2013, making it the 12th most populated country in the world. Population growth has primarily been due to a high birth rate and rising life expectancy. An increased elderly population is however a matter of concern for policy planners. The value of the pharmaceutical market in the country amounted to $4.3 billion in 2013, and it is expected to increase at a CAGR of 9.4% to reach approximately $8 billion in 2020.

The positive trend in the healthcare market of the Philippines can be attributed primarily to the following factors -

  • Generic substitution in both the public and private sectors, which has been a driver for the manufacture of generic drugs
  • Increased expenditure on medicines by Local Government Units (LGUs)
  • Government initiatives for the prevention and management of chronic diseases
  • An improved and updated regulatory environment

Scope

This report provides information on the healthcare, regulatory, and reimbursement landscape in the Philippines, including the following -

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses for major players in the pharmaceutical market (United Laboratories, Pfizer, GlaxoSmithKline, Novartis, Merck)
  • An insightful review of the reimbursement and regulatory landscape, including details of the healthcare reimbursement process, regulatory agencies, and approval processes for new drugs and medical devices
  • Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure, and healthcare expenditure
  • An overview of the opportunities for and challenges facing growth in the healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -

  • Develop business strategies based on a sound understanding of the trends shaping and driving the healthcare market in the Philippines
  • Generate revenue based upon knowledge of key trends, reimbursement and regulatory policies, pharmaceutical market segments, and the companies likely to impact the healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
  • Organize sales and marketing efforts by identifying the market categories and segments that present the greatest opportunities for consolidation, investment, and strategic partnership
  • Identify, understand, and capitalize upon the opportunities and challenges in the Philippines’ healthcare market

Table of Contents For This Report

Table of Contents

1 Table of Contents 6

1.1 List of Tables 9

1.2 List of Figures 12

2 Introduction 16

2.1 GlobalData Report Guidance 16

3 Overview of Pharmaceutical and Medical Device Market 17

3.1 Pharmaceutical Market 17

3.1.1 Market Overview 17

3.1.2 Pharmaceutical Exports and Imports 21

3.1.3 Supply Channels 22

3.1.4 Market Segments 24

3.1.5 Overview of Major Disease Areas 26

3.1.6 Major Players 28

3.2 Medical Device Market 70

3.2.1 Market Overview 70

3.3 Market Drivers and Barriers 70

3.3.1 Drivers 70

3.3.2 Barriers 71

4 Market Access 73

4.1 Reimbursement and Payer Landscape 73

4.1.1 Overview of Healthcare system 73

4.1.2 Reimbursement Process 74

4.1.3 Overview of Insurance Providers 78

4.1.4 Patient Share in Healthcare Spending 82

4.1.5 Price Trends in the Healthcare Sector 83

4.1.6 Pricing Policies 84

4.2 Regulatory Landscape 86

4.2.1 Overview of Regulatory Agencies 86

4.2.2 Market Authorization Procedure for Pharmaceutical Products 87

4.2.3 New Medical Device Approval Process 94

4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 94

4.2.5 Exports and Imports 95

4.2.6 Intellectual Property Rights 99

4.2.7 Clinical Trial Regulations 102

4.2.8 Pharmaceutical Advertising Regulations 105

4.2.9 Pharmacy Regulations 106

4.2.10 Labeling and Packaging Regulations 107

5 Country Analysis 109

5.1 Political Environment 109

5.1.1 Political Structure 109

5.1.2 Analysis of Current Political Environment 109

5.1.3 Healthcare Policy Initiatives 110

5.2 Economic Landscape 112

5.3 Economic Indicators 115

5.3.1 Gross Domestic Product 115

5.3.2 Gross National Income 120

5.3.3 Inflation 121

5.3.4 Currency Exchange Rate 123

5.3.5 Foreign Direct Investment 124

5.3.6 Foreign Exchange Reserves 125

5.3.7 Trade Balance 126

5.3.8 Fiscal Deficit 128

5.3.9 General Government Gross Debt 129

5.3.10 External Debt 130

5.3.11 Major Industries 131

5.4 Demographics 133

5.4.1 Population 133

5.4.2 Education and Literacy 151

5.4.3 Employment 153

5.4.4 Disease Burden 154

5.5 Healthcare Infrastructure 157

5.5.1 Healthcare Facilities 157

5.5.2 Healthcare Parameters 162

5.5.3 Environmental Health 164

5.5.4 Healthcare Personnel 167

5.6 Healthcare Expenditure 169

5.6.1 Overview 169

5.6.2 Major Components of Healthcare Spending 170

5.6.3 Share of Public and Private Sector 171

5.6.4 Spending in Pharmaceutical R&D 172

5.7 Trade Associations 172

5.7.1 Pharmaceutical and Healthcare Association of the Philippines 172

5.7.2 The Philippine Pharmaceutical Manufacturers Association 172

5.7.3 The Philippine Pharmacist Association 172

5.7.4 The Philippine Medical Association 173

5.8 Trade Fairs 173

6 Opportunities and Challenges 174

6.1 Opportunities 174

6.2 Challenges 175

7 Appendix 176

7.1 Abbreviations 176

7.2 Bibliography 179

7.3 Research Methodology 193

7.3.1 Coverage 193

7.3.2 Secondary Research 194

7.3.3 Forecasts 195

7.3.4 Expert Panel 195

7.4 Disclaimer 195

List of Tables

Table 1: Pharmaceutical Market, Philippines, Revenue ($bn), 2008-2013 19

Table 2: Pharmaceutical Market, Philippines, Revenue Forecast ($bn), 2014-2020 20

Table 3: Pharmaceutical Market, Philippines, Exports and Imports ($m), 2008-2013 21

Table 4: Pharmaceutical Market, Philippines, Price Distribution of Pharmaceuticals for Multinational Companies (%), 2008 23

Table 5: Pfizer, Global, Major Products, Revenue, 2013 34

Table 6: Pharmaceutical Market, Global, Late-Stage Pipeline, Pfizer, 2014 35

Table 7: GlaxoSmithKline, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2013 43

Table 8: Pharmaceutical Market, Global, Late-Stage Pipeline, GlaxoSmithKline, 2014 44

Table 9: Novartis, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2013 52

Table 10: Pharmaceutical Market, Global, Planned Filings, Novartis, 2014?2018 53

Table 11: Merck, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2013 63

Table 12: Pharmaceutical Market, Global, Late-Stage Pipeline, Merck, 2014 64

Table 13: Membership in PhilHealth, Philippines, Sector Share (%), 2013 81

Table 14: Benefit Payments from PhilHealth, Philippines, Sector Share (%), 2013 81

Table 15: Healthcare Spending, Philippines, Out-of-Pocket Expenditure (%), 2008-2013 83

Table 16: Price of Healthcare Products, Philippines Change in Average Price of Health Sector (%), 2008-2013 84

Table 17: Economic Indicators, Philippines, Gross Domestic Product per Capita ($), 2008-2013 116

Table 18: Economic Indicators, Philippines, Gross Domestic Product per Capita Forecast ($), 2014-2020 117

Table 19: Economic Indicators, Philippines, Gross Domestic Product Annual Growth (%), 2008-2013 118

Table 20: Economic Indicators, Philippines, Gross Domestic Product Annual Growth (%), 2014-2020 119

Table 21: Economic Indicators, Philippines, Gross National Income per Capita ($), 2008-2013 120

Table 22: Economic Indicators, Philippines, Average Consumer Price Index, 2008-2013 121

Table 23: Economic Indicators, Philippines, Average Consumer Price Annual Change (%), 2008-2013 122

Table 24: Economic Indicators, Philippines, Currency Exchange Rate (PHP/$), 2008-2013 123

Table 25: Economic Indicators, Philippines, Foreign Direct Investment ($bn), 2008-2013 124

Table 26: Economic Indicators, Philippines, Foreign Exchange Reserves ($bn), 2008-2013 125

Table 27: Economic Indicators, Philippines, Imports of Goods and Services ($bn), 2008-2013 126

Table 28: Economic Indicators, Philippines, Exports of Goods and Services ($bn), 2008-2013 127

Table 29: Economic Indicators, Philippines, Fiscal Deficit (% of GDP), 2008-2012 128

Table 30: Economic Indicators, Philippines, General Government Gross Debt (% of GDP), 2008-2013 129

Table 31: Economic Indicators, Philippines, External Debt ($bn), 2008-2013 130

Table 32: Economic Indicators, Philippines, Major Industries, Industrial Sector, Gross Value Added ($bn), 2012-2013 132

Table 33: Economic Indicators, Philippines, Major Industries, Service Sector, Gross Value Added ($bn), 2012-2013 133

Table 34: Demographics, Philippines, Population (million), 2008-2013 134

Table 35: Demographics, Philippines, Population Forecast (million), 2014-2020 135

Table 36: Demographics, Philippines, Population, Urban and Rural Population Share (%), 2008-2013 136

Table 37: Demographics, Philippines, Population, Urban and Rural Population Forecast Share (%), 2014-2020 137

Table 38: Demographics, Philippines, Population Distribution by Age Group (%), 2008-2013 138

Table 39: Demographics, Philippines, Population Distribution by Age Group Forecast (%), 2008-2013 139

Table 40: Demographics, Philippines, Births (per 1,000 Population), 2008-2013 140

Table 41: Demographics, Philippines, Mortality (per 1,000 Population), 2008-2013 141

Table 42: Demographics, Philippines, Major Causes of Mortality (‘000), 2010 142

Table 43: Demographics, Philippines, Infant Mortality (per 1,000 Live Births), 2008-2013 144

Table 44: Demographics, Philippines, Immunization Rate (%), 2008-2013 145

Table 45: Demographics, Philippines, Major Causes of Male Mortality (‘000), 2008 146

Table 46: Demographics, Philippines, Major Causes of Female Mortality (‘000), 2008 147

Table 47: Demographics, Philippines, Maternal Mortality (per 1,000 Live Births), 2008-2010 148

Table 48: Demographics, Philippines, Gender Ratio (M:F), 2008-2013 149

Table 49: Demographics, Philippines, Life Expectancy at Birth (Years), 2008-2013 150

Table 50: Demographics, Philippines, Life Expectancy at Birth (Years), 2014-2020 151

Table 51: Demographics, Philippines, Student Enrollment by Level of Education (%), 2008-2013 153

Table 52: Demographics, Philippines, Unemployment Rate (%), 2008-2013 153

Table 53: Demographics, Philippines, Major Diseases, Morbidity (‘000), 2010 155

Table 54: Demographics, Philippines, Major Diseases, DALYs (per 100,000 Population), 2009 156

Table 55: Healthcare Infrastructure, Philippines, Hospitals, 2008-2013 158

Table 56: Healthcare Infrastructure, Philippines, Barangay Health Stations, 2008-2013 159

Table 57: Healthcare Infrastructure, Philippines, Hospitals by Standard of Care, 2009 161

Table 58: Healthcare Infrastructure, Philippines, Diagnostic Equipment (per 100,000 Population), 2007-2009 162

Table 59: Healthcare Infrastructure, Philippines, Hospitals Beds (per 10,000 Population), 2008-2013 163

Table 60: Environmental Health, Philippines, CO2 Emissions (Million Tons), 2008-2013 165

Table 61: Environmental Health, Philippines, PM10 (µgm/m³), 2008-2013 166

Table 62: Healthcare Personnel, Philippines, Registered Healthcare Personnel, 2008-2013 168

Table 63: Healthcare Personnel, Philippines, Registered Nurses, 2008-2013 168

Table 64: Healthcare Expenditure, Philippines, Healthcare Expenditure (% of GDP), 2008-2013 169

Table 65: Healthcare Expenditure, Philippines, Share of Major Components (%), 2011 170

Table 66: Healthcare Expenditure, Philippines, Public-Private Share (%), 2008-2013 171

Table 67: Major Healthcare Trade Fairs, Philippines, 2014 173

List of Figures

Figure 1: Pharmaceutical Market, Philippines, Revenue ($bn), 2008-2013 19

Figure 2: Pharmaceutical Market, Philippines, Revenue Forecast ($bn), 2014-2020 20

Figure 3: Pharmaceutical Market, Philippines, Exports and Imports ($m), 2008-2013 21

Figure 4: Pharmaceutical Distribution Channel, Philippines, Distribution Share (%), 2008 22

Figure 5: Pharmaceutical Market, Philippines, Price Distribution of Pharmaceuticals for Multinational Companies (%), 2008 23

Figure 6: Healthcare Market, Philippines, Drivers and Barriers, 2013 72

Figure 7: Healthcare System, Philippines, 2014 73

Figure 8: Drug Selection Procedure for Philippine National Drug Formulary, Philippines, 2014 76

Figure 9: Reimbursement Process, Philippines, 2014 77

Figure 10: PhilHealth Milestones, Philippines, 2010 80

Figure 11: Membership in PhilHealth, Philippines, Sector Share (%), 2013 80

Figure 12: Benefit Payments from PhilHealth, Philippines, Sector Share (%), 2013 81

Figure 13: Healthcare Spending, Philippines, Out-of-Pocket Expenditure (%), 2008-2013 83

Figure 14: Price of Healthcare Products, Philippines, Change in Average Price of Health Sector (%), 2008-2013 84

Figure 15: Food and Drug Administration Structure, Philippines, 2014 87

Figure 16: Approval Process of New Drugs and Medical Devices, Philippines, 2014 90

Figure 17: Approval Process of Generic Drugs, Philippines, 2014 93

Figure 18: Bureau of Health Devices and Technology Structure, Philippines, 2014 94

Figure 19: Licensing Process for Manufacture of Pharmaceuticals and Medical Devices, Philippines, 2014 95

Figure 20: Patent Approval Process, Philippines, 2014 100

Figure 21: Trademark Approval Process, Philippines, 2014 101

Figure 22: Clinical Trial Approval Process, Philippines, 2014 104

Figure 23: Procedure for Opening a Retail Pharmacy, Philippines, 2014 107

Figure 24: Healthcare Policy Initiatives, Philippines, Major Healthcare Reforms, 1999-2010 112

Figure 25: Economic Indicators, Philippines, Gross Domestic Product per Capita ($), 2008-2013 116

Figure 26: Economic Indicators, Philippines, Gross Domestic Product per Capita Forecast ($), 2014-2020 117

Figure 27: Economic Indicators, Philippines, Gross Domestic Product Annual Growth (%), 2008-2013 118

Figure 28: Economic Indicators, Philippines, Gross Domestic Product Annual Growth Forecast (%), 2014-2020 119

Figure 29: Economic Indicators, Philippines, Gross National Income per Capita ($), 2008-2013 120

Figure 30: Economic Indicators, Philippines, Average Consumer Price Index, 2008-2013 121

Figure 31: Economic Indicators, Philippines, Average Consumer Price Annual Change (%), 2008-2013 122

Figure 32: Economic Indicators, Philippines, Currency Exchange Rate (PHP/$), 2008-2013 123

Figure 33: Economic Indicators, Philippines, Foreign Direct Investment ($bn), 2008-2013 124

Figure 34: Economic Indicators, Philippines, Foreign Exchange Reserves ($bn), 2008-2013 125

Figure 35: Economic Indicators, Philippines, Imports of Goods and Services ($bn), 2008-2013 126

Figure 36: Economic Indicators, Philippines, Exports of Goods and Services ($bn), 2008-2013 127

Figure 37: Economic Indicators, Philippines, Fiscal Deficit (% of GDP), 2008-2012 128

Figure 38: Economic Indicators, Philippines, General Government Gross Debt (% of GDP), 2008-2013 129

Figure 39: Economic Indicators, Philippines, External Debt ($bn), 2008-2013 130

Figure 40: Economic Indicators, Philippines, Major Industries, Industrial Sector, Gross Value Added ($bn), 2012-2013 131

Figure 41: Economic Indicators, Philippines, Major Industries, Service Sector, Gross Value Added ($bn), 2012-2013 132

Figure 42: Demographics, Philippines, Population (million), 2008-2013 134

Figure 43: Demographics, Philippines, Population Forecast (million), 2014-2020 135

Figure 44: Demographics, Philippines, Population, Urban and Rural Population Share (%), 2008-2013 136

Figure 45: Demographics, Philippines, Population, Urban and Rural Population Share Forecast (%), 2014-2020 137

Figure 46: Demographics, Philippines, Population Distribution by Age Group (%), 2008-2013 138

Figure 47: Demographics, Philippines, Population Distribution by Age Group Forecast (%), 2014-2020 139

Figure 48: Demographics, Philippines, Births (per 1,000 Population), 2008-2013 140

Figure 49: Demographics, Philippines, Mortality (per 1,000 Population), 2008-2013 141

Figure 50: Demographics, Philippines, Major Causes of Mortality (‘000), 2010 142

Figure 51: Demographics, Philippines, Infant Mortality (per 1,000 Live Births), 2008-2013 143

Figure 52: Demographics, Philippines, Immunization Rate (%), 2008-2013 145

Figure 53: Demographics, Philippines, Major Causes of Male Mortality (‘000), 2008 146

Figure 54: Demographics, Philippines, Major Causes of Female Mortality (‘000), 2008 147

Figure 55: Demographics, Philippines, Maternal Mortality (per 1,000 Live Births), 2008-2010 148

Figure 56: Demographics, Philippines, Gender Ratio (M:F), 2008-2013 149

Figure 57: Demographics, Philippines, Life Expectancy at Birth (Years), 2008-2013 150

Figure 58: Demographics, Philippines, Life Expectancy at Birth (Years), 2014-2020 151

Figure 59: Demographics, Philippines, Student Enrollment by Level of Education (%), 2008-2013 152

Figure 60: Demographics, Philippines, Unemployment Rate (%), 2008-2013 153

Figure 61: Demographics, Philippines, Major Diseases, Morbidity (‘000), 2010 154

Figure 62: Demographics, Philippines, Major Diseases, DALYs (per 100,000 Population), 2009 156

Figure 63: Healthcare Infrastructure, Philippines, Hospitals, 2008-2013 158

Figure 64: Healthcare Infrastructure, Philippines, Barangay Health Stations, 2008-2013 159

Figure 65: Healthcare Infrastructure, Philippines, Hospitals by Standard of Care, 2009 160

Figure 66: Healthcare Infrastructure, Philippines, Diagnostic Equipment (per 100,000 Population), 2007-2009 162

Figure 67: Healthcare Infrastructure, Philippines, Hospitals Beds (per 10,000 Population), 2008-2013 163

Figure 68: Environmental Health, Philippines, CO2 Emissions (Million Tons), 2008-2013 165

Figure 69: Environmental Health, Philippines, PM10 (µgm/m³), 2008-2013 166

Figure 70: Healthcare Personnel, Philippines, Registered Healthcare Personnel, 2008-2013 167

Figure 71: Healthcare Personnel, Philippines, Registered Nurses, 2008-2013 168

Figure 72: Healthcare Expenditure, Philippines, Healthcare Expenditure (% of GDP), 2008-2013 169

Figure 73: Healthcare Expenditure, Philippines, Share of Major Components (%), 2011 170

Figure 74: Healthcare Expenditure, Philippines, Public-Private Share (%), 2008-2013 171

Figure 75: Healthcare Market, Philippines, Opportunities and Challenges, 2013 175

Get Updates

Share This Post

Latest Reports from Life Sciences category

© 0211 MarketOptimizer.org. All rights reserved.